(Q30444762)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14769137%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

title

O6-benzylguanine suppression of O6-alkylguanine-DNA alkyltransferase in anaplastic gliomas (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14769137%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14769137%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

11

Michael D Prados

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14769137%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

3

Susan M Chang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14769137%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

9

Karen L Fink

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14769137%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

5

Kenneth R Hess

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14769137%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

1

S Clifford Schold

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14769137%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

author name string

Demetrius M Kokkinakis

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14769137%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

Mitchel S Berger

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14769137%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

David Schiff

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14769137%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

H Ian Robins

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14769137%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

R L Davis

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14769137%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

language of work or name

1 reference

1 January 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14769137%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14769137%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14769137%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14769137%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

page(s)

28-32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14769137%20AND%20SRC:MED&resulttype=core&format=json

Phase II trial of carmustine plus O(6)-benzylguanine for patients with nitrosourea-resistant recurrent or progressive malignant glioma

18 November 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871964

Thresholds of O6-alkylguanine-DNA alkyltransferase which confer significant resistance of human glial tumor xenografts to treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea or temozolomide

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871964

Phase I trial of carmustine plus O6-benzylguanine for patients with recurrent or progressive malignant glioma

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871964

Retrospective study of the correlation between the DNA repair protein alkyltransferase and survival of brain tumor patients treated with carmustine

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871964

Depletion of O6-alkylguanine-DNA alkyltransferase correlates with potentiation of temozolomide and CCNU toxicity in human tumour cells

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871964

O6-alkylguanine-DNA alkyltransferase and sensitivity to procarbazine in human brain-tumor xenografts

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871964

Multifaceted resistance of gliomas to temozolomide.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871964

Role of cytochrome P450 isoenzymes in metabolism of O(6)-benzylguanine: implications for dacarbazine activation.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871964

Eradication of human medulloblastoma tumor xenografts with a combination of O6-benzyl-2'-deoxyguanosine and 1,3-bis(2-chloroethyl)1-nitrosourea.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871964

O6-benzylguanine: a clinical trial establishing the biochemical modulatory dose in tumor tissue for alkyltransferase-directed DNA repair.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871964

Phase I trial of O6-benzylguanine for patients undergoing surgery for malignant glioma.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871964

O6-benzylguanine and its role in chemotherapy.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871964

Correlation of tumor O6 methylguanine-DNA methyltransferase levels with survival of malignant astrocytoma patients treated with bis-chloroethylnitrosourea: a Southwest Oncology Group study.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871964

Treatment of subcutaneous and intracranial brain tumor xenografts with O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1871964

Human liver oxidative metabolism of O6-benzylguanine

26 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/14769137

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Mechanism of depletion of O6-methylguanine-DNA methyltransferase activity in rat tissues by O6-Benzyl-2'-deoxyguanosine. Role of metabolism

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/14769137

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Phase I clinical and pharmacological study of O6-benzylguanine followed by carmustine in patients with advanced cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/14769137

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1215/S115285170300019X

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14769137%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14769137%20AND%20SRC:MED&resulttype=core&format=json

18 November 2019

1 reference